FrancophonIA/ELRC3.0 huggingface dataset:
English: Alcohol dehydrogenase preferentially metabolises ethanol prior to metabolising other alcohols, including propylene glycol.
Maltese: B'mod preferenzjali alcohol dehydrogenase jimmetabolizza lill-ethanol qabel ma jimmetabolizza lil alkoħols oħra, inkluż propylene glycol.
English: More seizures occurred with the higher dose of propylene glycol, where 33% of the infants had seizures, vs only 14% of infants who received the lower dose of propylene glycol.
Maltese: Aktar aċċessjonijiet seħħew bl-ogħla doża ta' propylene glycol, fejn 33% tat-tfal żgħar kellhom aċċessjonijiet, kontra 14% biss tat-tfal żgħar li rċevew id-doża l-baxxa ta' propylene glycol.
English: In conclusion given that Levothyroxine Alapis is a highly concentrated solution containing 100 mcg/ml the dropper device is considered to be unsuitable due to inaccuracies resulting from improper dropper orientation and miscounting, especially for paediatric initial doses less than 25 mcg.
Maltese: Bħala konklużjoni minħabba li Levothyroxine Alapis huwa soluzzjoni kkonċentrata ħafna li fiha 100 mcg/ml, il-qattara mhijiex ikkunsidrata adegwata minħabba żbalji li jirriżultaw minn orjentazzjoni ħażina tal-qattara u minn għadd ħażin, speċjalment għal dożi pedjatriċi tal-bidu ta' inqas minn 25 mcg.
English: As there is limited information on safe ethanol concentrations in paediatric formulations intended for chronic use, there are concerns with regard to chronic use of Levothyroxine Alapis in neonates/children, as ethanol represents an additional insult to brain development that is already compromised by congenital hypothyroidism.
Maltese: Peress li l-informazzjoni dwar konċentrazzjonijiet siguri ta' ethanol f'formulazzjonijiet pedjatriċi maħsuba għall-użu kroniku hija limitata, hemm tħassib fir-rigward tal-użu kroniku ta' Levothyroxine Alapis fit-trabi tat-twelid/tfal, peress li ethanol jirrappreżenta insult addizzjonali għalliżvilupp tal-moħħ li diġà huwa kompromess bl-ipotirojdiżmu konġenitali.
English: Medication errors caused by the administration device (dropper insert) Initially two different dropper inserts resulting in different drop sizes that would count up to 40 drops was proposed by the Applicant.
Maltese: Żbalji fl-għoti tal-mediċina kkawżati mill-apparat tal-għoti (qattara tal-flixkun) Inizjalment l-Applikant kien ippropona żewġ qattara differenti tal-flixkun li jirriżultaw f'qisien differenti ta' qtar li kellhom jgħoddu sa 40 qatra.
English: • The Committee concluded that the risk-benefit balance of Levothyroxine Alapis is therefore not considered to be favourable.
Maltese: • Il-Kumitat ikkonkluda li għalhekk, il-bilanċ tar-riskju-benefiċċju ta' Levothyroxine Alapis mhuwiex ikkunsidrat bħala favorevoli.
English: This is a bibliographic application that refers to literature concerning several levothyroxin tablet formulations and solutions and thus no reference is made to a single unique formulation.
Maltese: Din hija applikazzjoni biblijografika li tirreferi għar-riċensjoni dwar bosta formulazzjonijiet ta' pilloli u ta' soluzzjonijiet ta' levothyroxin u għalhekk ma hemm l-ebda referenza għal formulazzjoni waħda u unika.
English: Overall summary of the scientific evaluation of Levothyroxine Alapis and associated names (see Annex I)
Maltese: Sommarju ġenerali tal-evalwazzjoni xjentifika ta' Levothyroxine Alapis u ismijiet assoċjati (ara Anness I)
English: In light of the Applicant's failure to provide responses to the CHMP list of questions during the Article 29(4) referral procedure, the assessment was carried out on the data made available during the decentralised procedure and the CMDh referral procedure.
Maltese: Peress li l-Applikant naqas milli jipprovdi tweġibiet għal-lista ta' mistoqsijiet tas-CHMP matul ilproċedura ta' riferiment skont l-Artikolu 29(4), l-evalwazzjoni saret fuq id-dejta magħmula disponibbli matul il-proċedura ta' deċentralizzazzjoni u l-proċedura ta' riferiment tas-CMDh.
English: • The Committee was of the opinion that the chronic co-administration of the proposed quantities of the excipients ethanol and propylene glycol in children remains a safety concern.
Maltese: • Il-Kumitat kien tal-fehma li l-ko-amministrazzjoni kronika tal-kwantitajiet proposti tal-eċċipjenti ethanol u propylene glycol fit-tfal tibqa' ta' tħassib għas-sigurtà.
English: 1 An assessment of dose-uniformity of samples delivered from paediatric oral droppers, A.J.
Maltese: Riċensjoni ppubblikata1 tenfasizza l-potenzjal għal varjabbiltà
English: Since both propylene glycol and ethanol share a common metabolic pathway the combination of ethanol and propylene glycol is a concern.
Maltese: Peress li kemm propylene glycol kif ukoll ethanol għandhom rotta metabolika komuni, il-kombinazzjoni ta' ethanol u propylene glycol hija ta' tħassib.
English: Levothyroxine Alapis, which is formulated as a highly concentrated solution of a very potent active substance, is associated with adverse events with chronic over-dosing - particularly cardiovascular.
Maltese: Levothyroxine Alapis, li huwa fformulat bħala soluzzjoni konċentrata ħafna ta' sustanza attiva qawwija ħafna, huwa assoċjat ma' avvenimenti avversi b'għoti kroniku ta' dożaġġ li huwa aktar milli suppostb'mod partikolari kardjovaskulari.
English: In light of the failure to provide responses to the CHMP list of questions, , the available information was not considered to be sufficient to address the safety concerns of the chronic use of ethanol and the propylene glycol, in particular in the paediatric population.
Maltese: Fid-dawl tan-nuqqas ta' għoti ta' tweġibiet għal-lista ta' mistoqsijiet tas-CHMP, l-informazzjoni disponibbli ma kinitx ikkunsidrata suffiċjenti biex tindirizza t-tħassib dwar is-sigurtà tal-użu kroniku ta' ethanol u tal-propylene glycol, b'mod partikolari fil-popolazzjoni pedjatrika.
English: Therefore, co-administration of ethanol and propylene glycol can lead to raised and potentially toxic levels of the latter.
Maltese: Għalhekk, l-għoti flimkien ta' ethanol u propylene glycol jista' jwassal għal żieda fil-livelli u livelli potenzjalment tossiċi ta' dan tal-aħħar.
English: The national competent authorities, coordinated by the reference Member State, if applicable, shall ensure that the following conditions are fulfilled by the marketing authorisation holders:
Maltese: L-awtoritajiet nazzjonali kompetenti, ikkoordinati mill-Istat Membru ta' referenza, jekk applikabbli, għandhom jiżguraw li l-kundizzjonijiet li ġejjin jiġu ssodisfati mid-detenturi tal-awtorizzazzjoni għattqegħid fis-suq:
English: The MAHs should circulate a DHPC in accordance with the agreed key messages.
Maltese: Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq (MAH) għandu jiċċirkola DHPC f'konformità mal-messaġġi ewlenin maqbula.
English: 0.5ml (1mg/ml) 14 Vials
Maltese: 0,5ml (1mg/ml)
English: Packaging
Maltese: Kunjetti
English: Invented name Strength
Maltese: Numru ta' Proċedura ta' lEU
English: Subcutaneous use Vial (glass)
Maltese: Kunjett (talħġieġ)
English: It is ineffective against Enterobacteriaceae.
Maltese: Huwa ineffettiv kontra Enterobacteriaceae.
English: DK-2100 København Denmark
Maltese: DK-2100 København
English: 9 Nicholas RAJ, Fox LK, Lysnyansky I 2016.
Maltese: RAJ, Fox LK, Lysnyansky I 2016.
English: 1 CVMP reflection paper on the use of macrolides, lincosamides and streptogramins (MLS) in food-producing animals in the European Union: development of resistance and impact on human and animal health (EMA/CVMP/SAGAM/741087/2009) http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/11/WC500118230.pdf
Maltese: CVMP reflection paper on the use of macrolides, lincosamides and streptogramins (MLS) in food-producing animals in the European Union: development of resistance and impact on human and animal health (EMA/CVMP/SAGAM/741087/2009) http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/11/WC500118230.pdf effikaċja tagħhom u indikazzjonijiet ġenerali mingħajr bażi klinika solida għandhom jiġu evitati.
English: ESPECIALIDADES VETERINARIAS, S.A. A. Fuencarral Alcobendas km 15 700 Edificio Europa I Portal 3 2º5
Maltese: Fuencarral Alcobendas km 15 700 Edificio Europa I Portal 3 2º5
English: Wolfgang Schmälzl-Gasse 6 1020 Wien
Maltese: Wolfgang Schmälzl-Gasse 6 1020
English: He reported testing various antimicrobials, including tylosin.
Maltese: Hu rrapporta l-ittestjar ta' diversi antimikrobiċi, inkluż it-tilosina.
English: Rev. sci. tech. Off. int. Epiz.
Maltese: Rev. sci. tech.
English: Vetoquinol Biowet Sp. z o.o.
Maltese: Vetoquinol Biowet Sp. z o.o. ul.
English: Route of administration
Maltese: Rotta ta' amministrazzjoni
English: 29% of the composite samples (81/280) and 43% of the quarter milk samples (433/1008) did not yield growth of Mycoplasma.
Maltese: jiġu evalwati t-tendenzi tat-tifrix. 29 % tal-kampjuni komposti (81/280) u 43 % tal-kampjuni tal-ħalib ta' kwart (433/1008) ma pproduċewx tkabbir ta' Mikoplażma.
English: Vetoquinol Scandinavia AB Lyngbyvej 20
Maltese: Id-Danimarka Vetoquinol Scandinavia AB Lyngbyvej 20
English: VETOQUINOL SA/NV Kontichsesteenweg 42 2630 Aartselaar Belgium
Maltese: VETOQUINOL SA/NV Kontichsesteenweg 42 2630
English: Mycoplasma and mycoplasma mastitis; JAVMA 1977 Vol. 170 No.10: 1167-1171
Maltese: JAVMA 1977 Vol. 170 No.10: 1167-1171
English: United Kingdom Vetoquinol UK Ltd Vetoquinol House
Maltese: Vetoquinol UK Ltd Vetoquinol House Great Slade
English: Monitoring the lack of efficacy is a part of the veterinary pharmacovigilance system.
Maltese: Il-monitoraġġ tan-nuqqas ta' effikaċja huwa parti mis-sistema tal-farmakoviġilanza veterinarja.
English: Mycoplasma mastitis in cattle: To cull or not to cull.
Maltese: To cull or not to cull.
English: Current technologies such as Polymerase Chain Reaction (PCR) have enabled significantly quicker identification of M. bovis.
Maltese: Teknoloġiji attwali bħal Reazzjoni Katina bil-Polimerażi (PCR, Polymerase Chain Reaction) ippermettew identifikazzjoni ferm aktar malajr ta' M. bovis.
English: Tylosin is a macrolide antibiotic which is produced by Streptomyces fradiae.
Maltese: It-tilosina huwa antibijotiku makrolidu prodott minn Streptomyces fradiae.
English: Mycoplasma bovis infections in cattle; J Vet Intern Med; 2011: 25:772-783 8 Fox LK 2012.
Maltese: Mycoplasma bovis infections in cattle; J Vet Intern Med; 2011: 25:
English: Slovak Republic Biovet JSC 39 Petar Rakov Str.
Maltese: Is-Slovakkja Biovet JSC 39 Petar Rakov Str.
English: 189 Lure Cedex
Maltese: Magny-Vernois B.P. 189 Lure Cedex
English: The marketing authorisation holder for the reference medicinal product ‘Tylan 200 mg/ml', Elanco Animal Health, agreed with the concerns raised and concluded that there is a lack of reliable pre-clinical and clinical data in support of the respective indication.
Maltese: Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq għall-prodott mediċinali ta' referenza “Tylan 200 mg/ml”, Elanco Animal Health, qabel mat-tħassib imqajjem u kkonkluda li hemm nuqqas ta' data preklinika u klinika li tappoġġja l-indikazzjoni rispettiva.
English: Therefore, on 22 June 2016, Finland initiated a referral procedure under Article 35 of Directive 2001/82/EC, for veterinary medicinal products containing tylosin that are administered parenterally and intended for the treatment of bovine mastitis caused by Mycoplasma spp.
Maltese: Għalhekk, fit-22 ta' Ġunju 2016, il-Finlandja bdiet proċedura ta' referenza skont l-Artikolu 35 tadDirettiva 2001/82/KE, għal prodotti mediċinali veterinarji li fihom it-tilosina li jingħataw b' mod parenterali u li huma intiżi għall-kura ta' mastite bovina kkawżata minn Mycoplasma spp.
English: was as high as 53% (8/15) (Jasper (1977)).
Maltese: Il-propozjon ta' baqar li nstabu li huma pożittivi għal M. bovis wara 5 ijiem ta' kura bittilosina (3g/baqra/jum i.m.) kien għoli daqs 53 % (8/15) (Jasper (1977)).
English: HUVEPHARMA Uitbredingstraat 53 2600 Antwerp Belgium
Maltese: HUVEPHARMA Uitbredingstraat 53 2600
English: Infected cows may remain externally normal with few clinical signs, even in severe cases.
Maltese: Il-baqar infettati jibqgħu esternament normali bi ftit sinjali kliniċi, anki f' każijiet severi.
English: In 1977 Jasper 2 described natural resolution of the disease as unpredictable and recognised the danger of intermittently shedding cows.
Maltese: Fl-1977, Jasper iddeskriva riżoluzzjoni naturali tal-marda bħala waħda mhux prevista u rrikonoxxa lperiklu ta' baqar li jifirixu l-patoġenu b' mod intermittenti.
English: Mycoplasma bovis: disease, diagnosis and control; Res. Vet. Sci. 2003: 74: 105-112
Maltese: Mycoplasma bovis: disease, diagnosis and control; Res.
English: Slovak Republic Vétoquinol s.r.o.
Maltese: Vétoquinol s.r.o.
English: Finland noted that there are veterinary medicinal products containing tylosin that are administered parenterally and intended for the treatment of bovine mastitis caused by Mycoplasma spp.
Maltese: Il-Finlandja nnutat li hemm prodotti mediċinali veterinarji li fihom it-tilosina li jingħataw b' mod parenterali u li huma intiżi għall-kura ta' mastite bovina kkawżata minn Mycoplasma spp.
English: Belgium Cross Vetpharma Group Ltd Broomhill Road, Tallagh Dublin 24
Maltese: Cross Vetpharma Group Ltd Broomhill Road, Tallagh Dublin 24
English: It is active mostly against Gram-positive bacteria and mycoplasmas.
Maltese: Huwa attiv l-iktar kontra batterji Gram-pożittivi u mikoplażmi.
English: Tylosin belongs to macrolides which have been classified as critically important antimicrobials both in veterinary and human medicine.
Maltese: It-tilosina jappartjeni għal makrolidi li ġew ikklassifikati bħala antimikrobiċi kritikament importanti kemm fil-mediċini tal-bniedem kif ukoll dik veterinarja.
English: Vétoquinol SA, Magny-Vernois 70200 Lure France
Maltese: Vétoquinol SA, Magny-Vernois 70200
English: Special media and atmosphere are required and the incubation period is long (7-10 days).
Maltese: Huma meħtieġa midja u atmosfera speċjali u l-perjodu ta' inkubazzjoni huwa twil (7-10 ijiem).
English: List of the names, pharmaceutical forms, strengths of the veterinary medicinal products, animal species, routes of administration and applicants/marketing authorisation holders in the Member States
Maltese: Lista tal-ismijiet, għamliet farmaċewtiċi, qawwiet tal-prodotti mediċinali veterinarji, speċi tal-annimali, rotot ta' amministrazzjoni u applikanti/detenturi tal-awtorizzazzjoni għat-tqegħid fis-suq fl-Istati Membri
English: The use of tylosin as a veterinary medicine has been discussed in the CVMP reflection paper on the use of macrolides, lincosamides and streptogramins (MLS) in food-producing animals in the European Union: development of resistance and impact on human and animal health (EMA/CVMP/SAGAM/741087/2009)1.
Maltese: L-użu tat-tilosina bħala mediċina veterinarja ġie diskuss fid-dokument ta' riflessjoni tas-CVMP dwar lużu tal-makrolidi, tal-linkosamidi u tal-istreptogramini (MLS, macrolides, lincosamides and streptogramins) f' annimali li jipproduċu l-ikel fl-Unjoni Ewropea: żvilupp ta' reżistenza u impatt fuq is-saħħa tal-bniedem u tal-annimali (EMA/CVMP/SAGAM/741087/2009)
English: The clinical signs vary but the milk loss is usually significant.
Maltese: Is-sinjali kliniċi jvarjaw iżda t-telf talħalib normalment ikun sinifikanti.
English: Tylosin and its phosphate and tartrate salts are used in veterinary medicines for the treatment of conditions caused by sensitive organisms.
Maltese: It-tilosina u l-imluħa fosfati u tartratiċi tiegħu jintużaw f' mediċini veterinarji għall-kura ta' kondizzjonijiet ikkawżati minn organiżmi sensittivi.
English: or Mycoplasma bovis'.
Maltese: Mycoplasma and mycoplasma mastitis;
English: Cattle Calves Sheep Goats Pigs Dogs
Maltese: INYECTABLE PARA BOVINO OVINO CAPRINO Y PORC
English: Delete, where applicable, the indication ‘bovine mastitis caused by Mycoplasma spp.'.
Maltese: Ħassar, fejn applikabbli, l-indikazzjoni “mastite bovina kkawżata minn Mycoplasma spp.”.
English: VETOQUINOL SA Magny Vernois 70200 LURE France
Maltese: VETOQUINOL SA Magny Vernois 70200
English: Huvepharma N.V. Uitbreidingsstraat 80 2600 Antwerpen Belgium
Maltese: Huvepharma N.V. Uitbreidingsstraat 80 2600
English: VETOQUINOL Magny Vernois 70200 Lure France
Maltese: VETOQUINOL Magny Vernois 70200
English: Belgium
Maltese: Antwerpen Belgium
English: 1996, 15(4), 1477-1494 5 Nicholas RAJ and Ayling R 2003.
Maltese: Vet. Sci. 2003: 74: 105-112 Gonzalez RN and Wilson DJ 2003.
English: Finland noted that in the current scientific literature there is no support for the indication 'bovine mastitis caused by Mycoplasma bovis', but instead it is widely stated that there are no antimicrobial treatment options for bovine mastitis caused by mycoplasma.
Maltese: Il-Finlandja nnutat li fir-riċensjoni xjentifika attwali m' hemm l-ebda appoġġ għall-indikazzjoni “mastite bovina kkawżata minn Mycoplasma bovis”, iżda minflok huwa ddikjarat b' mod komuni li m' hemm l-ebda għażla ta' kura bl-antimikrobiċi għal mastite bovina kkawżata minn mikoplażma.
English: Vetoquinol Italia S.r.l.
Maltese: Vetoquinol Italia S.r.l. Via Piana 265
English: Finland considered that ineffective treatment of mycoplasma mastitis with tylosin presents a serious concern to animal and human health as it delays the correct diagnosis, enables spread of the pathogen to other cows, impedes efficient/prudent control measures and increases risk for the development of antimicrobial resistance due to unnecessary use of antimicrobials.
Maltese: Barra minn hekk, il-Kumitat ikkonkluda li kura bl-antimikrobiċi ineffiċjenti bit-tilosina ddewwem id-dijanjożi korretta, timpedixxi miżuri ta' kontroll effiċjenti u tippermetti t-tixrid talpatoġenu, b' hekk tpoġġi f' riskju t-trattament tal-annimali, waqt li tikkawża telf ekonomiku sever u riskju għal żieda fl-użu u fir-reżistenza antimikrobiċi.
English: VETOQUINOL SA Magny-Vernois 70200 Lure France
Maltese: VETOQUINOL SA Magny-Vernois 70200
English: Mycoplasma spp.
Maltese: Streptococcus spp., Staphylococcus spp.).
English: Mycoplasmas do not grow on conventional media; this hampers the diagnosis.
Maltese: Il-mikoplażmi ma jikbrux fuq midja konvenzjonali; dan ifixkel id-dijanjożi.
English: • in the absence of pre-clinical or clinical data and in light of the current scientific knowledge the CVMP considered that the treatment of bovine mastitis caused by Mycoplasma spp.
Maltese: • fin-nuqqas ta' data preklinika jew klinika u fid-dawl tal-għarfien xjentifiku attwali, is-CVMP ikkunsidra li l-kura ta' mastite bovina kkawżata minn Mycoplasma spp bi prodotti mediċinali veterinarji li fihom it-tilosina li jingħataw b' mod parenterali mhijiex effettiva;
English: Macrolides are categorised as critically important antimicrobials both in human and veterinary medicine however tylosin is not used in human medicine.
Maltese: Il-makrolidi huma kkategorizzati bħala antimikrobiċi kritikament importanti kemm fil-mediċina tal-bniedem kif ukoll f' dik veterinarja, madankollu t-tilosina ma jintużax fil-mediċina tal-bniedem.
English: Despite the improved diagnostic technologies, a major challenge in the diagnosis of mycoplasma mastitis (and in assessing success of antimicrobial treatment) remains that the pathogen may be shed intermittently in the milk of infected cows.
Maltese: Minkejja t-teknoloġiji dijanjostiċi mtejba, għad hemm sfida ewlenija fid-dijanjożi tal-mastite bilmikoplażma (u fil-valutazzjoni tas-suċċess ta' kura bl-antimikrobiċi) li l-patoġenu jista' jinxtered b' mod intermittenti fil-ħalib ta' baqar infettati.
English: Gonzalez RN and Wilson DJ 2003.
Maltese: Nicholas RAJ and Ayling R 2003.
English: The major pathogen among the genera is Mycoplasma bovis that was first isolated from bovine mastitis in the USA in the 1960s.
Maltese: Il-patoġenu ewlieni fost il-ġeneri huwa Mycoplasma bovis li l-ewwel kien iżolat mill-mastite bovina fl-Istati Uniti fis-sittinijiet.
English: Huvepharma N.V. Uitbreidingstraat 80 2600 Antwerpen Belgium
Maltese: Huvepharma N.V. Uitbreidingstraat 80 2600
English: TYLUCIL 200 mg/ml SOLUCIÓN INYECTABLE
Maltese: TYLUCIL 200 mg/ml SOLUCIÓN
English: A thorough literature search to find new data on the efficacy of tylosin in the treatment of mycoplasma mastitis revealed no original studies.
Maltese: Tfittxija bir-reqqa fil-letteratura sabiex tinstab data ġdida dwar l-effikaċja tat-tilosina fil-kura ta' mastite bil-mikoplażma ma wriet l-ebda studju oriġinali.
English: The dose 3 g/cow/day is within the dose range widely authorised in Europe i.e. 4-10 mg/kg/day i.m.
Maltese: Id-doża 3 g/baqra/jum tinsab fil-medda tad-doża li hi awtorizzata madwar l-Ewropa jiġifieri, 4-10 mg/kg/jum i.m.
English: No pre-clinical or clinical data in support of the indication were provided from the applicants/marketing authorisation holders and no benefits of the use on tylosin in treatment of mastitis caused by Mycoplasma spp.
Maltese: L-applikanti/id-detenturi tal-awtorizzazzjoni għat-tqegħid fis-suq ma pprovdew l-ebda data preklinika jew klinika biex tappoġġja l-indikazzjoni u ma ġie identifikat l-ebda benefiċċju tal-użu tat-tilosina filkura ta' mastite kkawżata minn Mycoplasma spp.
English: HUVEPHARMA NV Uitbreidingstraat 80 2600 Anversa Belgium
Maltese: Huvepharma NV Uitbreidingstraat 80 2600
English: Mastitis caused by M. bovis differs in several ways from infections caused by the majority of more common mastitis pathogens (e.g. Streptococcus spp., Staphylococcus spp.).
Maltese: Mastite kkawżata minn M. bovis hija differenti b' diversi modi minn infezzjonijiet ikkawżati millmaġġoranza tal-patoġeni aktar komuni tal-mastite (eż.
English: 4.9 Amounts to be administered and administration route Delete, where applicable, any specific dosing recommendation related to ‘bovine mastitis caused by Mycoplasma spp.'.
Maltese: 4.9 Ammonti li għandhom jingħataw u rotta ta' amministrazzjoni Ħassar, fejn applikabbli, kwalunkwe rakkomandazzjoni tad-dożaġġ relatata ma' “mastite bovina kkawżata minn Mycoplasma spp.”
English: DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION Delete, where applicable, any specific dosing recommendation related to ‘bovine mastitis caused by Mycoplasma spp.'.
Maltese: Ħassar, fejn applikabbli, kwalunkwe referenza għal “mastite bovina kkawżata minn Mycoplasma spp. jew Mycoplasma bovis”.
English: Patterns of mycoplasma shedding in the milk of dairy cows with intramammary mycoplasma infection.
Maltese: Patterns of mycoplasma shedding in the milk of dairy cows with intramammary mycoplasma infection. J Am Vet Med Association 2003, 223 (8) 1163-1166
English: the CVMP has recommended the variation of the marketing authorisations for veterinary medicinal products containing tylosin that are administered parenterally and intended for the treatment of bovine mastitis caused by Mycoplasma spp.
Maltese: Sommarju ġenerali tal-valutazzjoni xjentifika ta' prodotti mediċinali veterinarji li fihom it-tilosina li jingħataw b' mod parenterali u li huma intiżi għall-kura ta' mastite bovina kkawżata minn Mycoplasma spp. (ara Anness I)
English: For the same reasons sensitivity testing of Mycoplasma spp.
Maltese: Għall-istess raġunijiet, littestjar tas-sensittività ta' Mycoplasma spp. huwa diffiċli.
English: PHARMASIN 200 MG/ML SOLUTION INJECTABLE POUR BOVINS OVINS CAPRINS ET PORCINS
Maltese: MG/ML SOLUTION INJECTABLE POUR BOVINS OVINS CAPRINS ET PORCINS
English: Instead several comprehensive review articles dealing with mycoplasma mastitis have been published (Pfützner and Sachse (1996)4, Nicholas and Ayling (2003)5, Gonzalez and Wilson (2003)6, Maunsell et al. (2011)7, Fox (2012)8, Nicholas et al. (2016)9).
Maltese: Gonzalez u Wilson (2003) 6, Maunsell et al.
English: Mastitis caused by M. bovis differs in several ways from infections caused by the majority of the more common mastitis pathogens (e.g. Streptococcus spp., Staphylococcus spp.).
Maltese: Streptococcus spp., Staphylococcus spp.). M. bovis huwa patoġenu tal-beżżula kontaġġjuż ħafna li normalment jikkawża mastite li taffettwa diversi kwartijiet (robbi) peress li huwa kapaċi jinfirex ematoloġikament.
English: 4.5 Special precautions for use
Maltese: 4.5 Prekawzjonijiet speċjali għall-użu
English: 10 April 2014 (DLP:22 January 2012)
Maltese: (DLP:22 ta' Jannar 2012)
English: The MAH(s) should submit the next yearly PSUR by:
Maltese: Il-MAH(s) għandu(hom) jissottometti(u) l-PSUR annwali li ġej sa: